ArticleUpdates in surgery2025
Ultrasound guided-transabdominal plane block (UG-TAPB) reduces pain, opioid consumption and PONV, and is associated with faster recovery for patients undergoing bariatric surgery: a retrospective analysis in a high-volume Italian center.
Article in Updates in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ultrasound-guided Transversus Abdominis Plane Block (UG-TAPB) reduces post-operative pain better than i.v. painkillers in patients operated with laparoscopic surgery. This study aims to compare the postoperative course of patients undergoing bariatric surgery treated with UG-TABP to that of patients treated with standard analgesic therapy. We retrospectively analyzed patients who have undergone bariatric surgery from November 2021 to April 2023, comparing patients treated with UG-TAPB (Group A) with patients treated with standard i.v. analgesic therapy (Group B). Post-operative numeric-pain rating scale (NRS), nausea and vomiting (PONV), opioid and antiemetic consumption were compared between the two groups until postoperative day (POD) 2. 41 patients underwent bariatric surgery in the aforementioned period. 11 patients were included in group A, whereas 30 patients were included in group B. The two groups were homogeneous for age, BMI, surgery type and comorbidities. Females were more common in Group B (64% vs. 80%; p = 0.019). NRS was significantly lower in Group A than Group B from POD0 to POD2 (3.8 ± 1.2 vs. 6.1 ± 2; p = 0.001 and 1.1 ± 0.3 vs. 3.1 ± 1.3; p < 0.001 after surgery and on POD2 8 pm, respectively). On POD 0, opioid consumption (9% vs. 57%; p = 0.011 and 9% vs. 47%; p = 0.033 after surgery and at 8 pm, respectively), PONV (27% vs. 90%; p < 0.001 and 9% vs. 57%; p = 0.011) and antiemetic consumption (36% vs. 90%; p = 0.001 and 9% vs. 53%; p = 0.014) were higher in Group B. Patients in Group A can be discharged earlier than patients in Group B (1.45 ± 0.82 vs. 2.67 ± 1.39 days; p = 0.005). UG-TAPB is associated with a better and faster recovery after bariatric surgery and should be considered in ERABS.
Indexed as
Identifiers
39681825What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.